VX-702
- Soluble in DSMO
- MF: C19H12F4N4O2
- MW: 404.32
Description
VX-702 is an orally bioavailable p38 MAP kinase inhibitor developed to treat inflammatory diseases.
More Information
| Parent CAS No. | 479543-46-9 |
|---|---|
| Chemical Name | 2-(2,4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide |
| extra_info | Sold in collaboration with Chemietek |
| MFCD | N.A. |
| Short Description | p38 MAP kinase inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1357 | SD 169 |
From $66.00 |
| 1358 | BIRB 796 |
From $71.50 |
| 1363 | SB 203580 |
From $104.50 |
| 1364 | SB 202190 |
From $104.50 |
| 1365 | PD169316 |
From $104.50 |
| 1465 | SB 203580 hydrochloride |
From $77.00 |
| 1671 | SCIO 469 |
From $132.00 |
| 1811 | VX 745 |
From $99.00 |
| 1837 | PH 797804 |
From $126.50 |
| 1895 | LY 2228820 |
From $115.50 |
| 2444 | SB 706504 |
From $137.50 |
| 2717 | Apigenin |
From $77.00 |
| 2786 | (±)-PH 797804 |
From $126.50 |
| 2856 | BMS 582949 |
From $170.50 |
| 3183 | SR-318 |
From $132.00 |
| 3197 | Mitochonic acid 5 |
From $99.00 |
| 3440 | MK2 inhibitor III |
From $132.00 |
| 3620 | MAPK13 inhibitor compound 61 |
From $154.00 |
| 5010 | Naive Stem Cell NHSM inhibitor Set |
From $253.00 |
